Home › Funds › Castlefield Investment Partners LLP › BSX

Castlefield Investment Partners LLP position in BSX

BOSTON SCIENTIFIC CORP · Health Care

Castlefield Investment Partners LLP reported holding 67,559 shares of BSX (BOSTON SCIENTIFIC CORP) in its Q3 2026 13F filing — a position valued at US$2.9M, representing 1.92% of its reported portfolio and ranking #26 among its reported holdings. Castlefield Investment Partners LLP has disclosed BSX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)67.56K sh
Reported value held$2.95M
Portfolio Weight1.92%
First reportedQ4 2025
Last changeAdd
Updated2026-11-12

Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR

How Castlefield Investment Partners LLP's BSX position evolved

Castlefield Investment Partners LLP first disclosed a stake in BSX in Q4 2025 at 47,626 shares (US$4.5M). Across 4 filings, Castlefield Investment Partners LLP increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 67,559 shares valued at US$2.9M — an increase of 10,652 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2025 47.63K $4.54M New
Q1 2026 53.86K $3.38M Add
Q2 2026 56.91K $2.43M Add
Q3 2026 67.56K $2.95M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BSX and 13F data

BSX (BOSTON SCIENTIFIC CORP) is a Health Care company. 19 other funds we track also report a position in BSX — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$2.16B), D. E. Shaw & Co (US$1.16B), Janus Henderson Group (US$1.04B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BSX

All BSX fund holders →

FAQ

How long has Castlefield Investment Partners LLP held BSX?

Castlefield Investment Partners LLP has disclosed BSX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Castlefield Investment Partners LLP's current position in BSX?

As of Q3 2026, Castlefield Investment Partners LLP holds 67.56K shares of BSX (BOSTON SCIENTIFIC CORP), valued at $2.95M, representing 1.92% of its reported portfolio and ranking #26.

Has Castlefield Investment Partners LLP been buying or selling BSX?

In the latest 13F filing (Q3 2026), Castlefield Investment Partners LLP increased its position in BSX.

Which other funds hold BSX?

Other major institutional holders of BSX include PRIMECAP MANAGEMENT CO/CA/, D. E. Shaw & Co, Janus Henderson Group, among 19 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.